Trial · NCT03703882
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in North Star Ambulatory Assessment (NSAA) | Dose 1 | -1.5 | Standard Deviation 4.41 | score on a scale | |
| Change From Baseline in North Star Ambulatory Assessment (NSAA) | Placebo | -1.8 | Standard Deviation 3.81 | score on a scale | |
| Change From Baseline in 10-meter Walk/Run Test | Dose 1 | -0.0058 | Standard Deviation 0.03010 | score on a scale | |
| Change From Baseline in 10-meter Walk/Run Test | Placebo | -0.0093 | Standard Deviation 0.02538 | score on a scale | |
| Change From Baseline in Time to Stand From Supine | Dose 1 | -0.0389 | Standard Deviation 0.06728 | score on a scale | |
| Change From Baseline in Time to Stand From Supine | Placebo | -0.0459 | Standard Deviation 0.06171 | score on a scale | |
| Change From Baseline in 4-stair Climb | Dose 1 | -0.0220 | Standard Deviation 0.08920 | score on a scale | |
| Change From Baseline in 4-stair Climb | Placebo | -0.0392 | Standard Deviation 0.07352 | score on a scale | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Dose 1 | Treatment Emergent Adverse Event (TEAEs) | 85 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Placebo | Treatment Emergent Adverse Event (TEAEs) | 41 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Dose 1 | Related Treatment Emergent Adverse Event (TEAEs) | 61 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Placebo | Related Treatment Emergent Adverse Event (TEAEs) | 14 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Dose 1 | Serious TEAE | 1 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Placebo | Serious TEAE | 1 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Dose 1 | Serious Related TEAEs | 0 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Placebo | Serious Related TEAEs | 0 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Dose 1 | TEAEs Leading to Study Discontinuation | 1 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Placebo | TEAEs Leading to Study Discontinuation | 0 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Dose 1 | Treatment-Related TEAEs Leading to Study Discontinuation | 1 | participants | |
| Safety and Tolerability Measured by Number of Treatment- Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Placebo | Treatment-Related TEAEs Leading to Study Discontinuation | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03703882/results